Enzo Biochem, Inc. (ENZB)
OTCMKTS
· Delayed Price · Currency is USD
0.6705
-0.0050 (-0.74%)
At close: Jun 27, 2025
Enzo Biochem Employees
As of July 31, 2024, Enzo Biochem had 136 total employees, including 125 full-time and 11 part-time employees. The number of employees decreased by 54 or -28.42% compared to the previous year.
Employees
136
Change (1Y)
-54
Growth (1Y)
-28.42%
Revenue / Employee
$209,725
Profits / Employee
-$160,931
Market Cap
28.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
American Oncology Network | 1,914 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
Enzo Biochem News
- 1 day ago - ENZO BIOCHEM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enzo Biochem, Inc. - ENZB - Business Wire
- 3 days ago - ENZB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enzo Biochem, Inc. Is Fair to Shareholders - Business Wire
- 3 days ago - Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction - GlobeNewsWire
- 11 days ago - Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 2 months ago - Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction - GlobeNewsWire
- 3 months ago - Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - GlobeNewsWire
- 3 months ago - Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 5 months ago - Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - GlobeNewsWire